Effect of combination therapy with thyroxine (T4) and 3,5,3′-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study

European Journal of Endocrinology

Volumn 161, Issue 6, 2009, Pages 895-902

  Nygaard, Birte ^a   Jensen, Ebbe Winther ^a   Kvetny, Jan ^b   Jarløv, Anne ^c   Faber, Jens ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Esbjerg   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE I 131; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY WEIGHT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HEART PALPITATION; HORMONE SUBSTITUTION; HUMAN; HYPERHIDROSIS; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; MONOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SYMPTOM CHECKLIST 90; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGED; ANTITHYROID AGENTS; CROSS-OVER STUDIES; DEPRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; QUALITY OF LIFE; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 72849126078     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0542     Document Type: Article

References (25)

1. Leonard JL & Koehrle J. Intracellular pathways of iodothyronine metabolism. In Werner and Ingbar's the Thyroid. A Fundamental and Clinical Text, edn 7, pp 125-161. Eds LE Bravermann & RD Utiger. Philadelphia: Lippencott-Raven, 1996.
2. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzoula F & Bianchi R. Thyroidal and peripheral production of 3,5,3′-triiodithyronine in humans by multicompartmental analysis. American Journal of Physiology 1990 258 E715-E726.
3. Kaplan MM & Yaskoski KA. Phenolic and thyrosyl ring deiodination of iodothyronines in rat brain homogenates. Journal of Clinical Investigation 1980 66 551-562.
4. van Doorn J, Roelfsema F & van der Heide D. Concentration of thyroxine and 3,5,30 triiodothyronine at 34 different sites in euthyroid rats as determined by an isometric equilibrium technique. Endocrinology 1985 117 1201-1208.
5. Escobar-Morreale HF, Escobar del Rey F, Obregon MJ & Morealle de Escobar G. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues in the thyroidectomized rat. Endocrinology 1996 137 2490-2502.
6. Woeber KA. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. Journal of Endocrinological Investigation 2002 25 106-109.
7. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R & Dayan CM. Psychological well-being in patients on adequate doses of L-thyroxine: result of a large controlled community-based questionnaire study. Clinical Endocrinology 2002 57 577-585.
8. Bunevicius R, Kazanavicius G, Zalinkevicius R & Prange AJ. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. New England Journal of Medicine 1999 340 424-470.
9. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A & Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism. Metaanalysis of randomized controlled trials. Journal of Clinical Endocrinology and Metabolism 2006 91 2562-2599.
10. Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, Dhaliwal SS, Chew GT, Bhagat MC & Cussons AJ. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2003 88 4543-4550.
11. Bjørner JB, Damsgaaard MT, Watt T, Bech P, Rasmusen NK, Kristensen TS, Modvig J & Thunedborg K. Danish Manual to SF-36. A questionaire to health status. Copenhagen, LIF, 1997.
12. Beck AT & Steer RA. Beck depression inventory. In Handbook of Psychiatric Measures, pp 519-523. Eds AJ Rush, HA Pincus & MB Fist,Washington DC: American Psychiatric Association Press, 2000.
13. Derogatis LR. SCL-90R, Symptom Checklist-90-R. Vejledning til Administration og Scoring. Copenhagen, Dansk Psykologisk Forlag. 2007.
14. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 1979 6 65-70.
15. Benjamini Y, Drai D, Elmer G, Kafkafi N & Golani I. Controlling the false discovery rate in behavior genetics research. Behavioural Brain Research 2001 125 279-284.
16. Appelhof BC, Fliers E, Wekking EM, Schene AH, Heyser J, Tijssen JGP, Endert E, van Weert HCMP & Wiersinga WM. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind randomized controlled clinical trial. Journal of Clinical Endocrinology and Metabolism 2005 90 2666-2674.
17. 4 replacement therapy: results of a large communitybased randomized controlled study. Journal of Clinical Endocrinology 2005 90 805-812.
18. Larsen PR. Thyroid-pituitary interaction: feedback regulation of thyrotrophine secretion by thyroid hormone. New England Journal of Medicine 1982 306 23-32.
19. Smith RN, Taylor SA & Massey JC. Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. BMJ 1970 4 145-148.
20. Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V & Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Annals of Internal Medicine 2005 142 412-424.
21. Kirkegaard C & Faber J. The role of thyroid hormones in depression. European Journal of Endocrinology 1998 138 1-9.
22. 4 alone in patients with hypothyroidism? Results of a double-blind, randomized controlled trial Journal of Clinical Endocrinology and Metabolism 2003 88 4551-4555.
23. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuioer GG, Uitterlinden AG & Visser TJ. Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 2880-2888.
24. Appelhof BC, Peeters RP, Wiersinga WM, Visser TJ, Wekking EM, Huyser J, Schene AH, Tijssen JG, Hoogendijk WJ & Fliers E. Polymorphisms in type 2 deiodinase are not associated with wellbeing, neurocognitive functioning, and preference for combined thyroxine/3,5,3′-triiodothyronine therapy. Journal of Clinical Endocrinology and Metabolism 2005 90 6296-6299.
25. Van der Deure WM, Appelhof BC, Peters RP, Wiersinga WM, Wekking EM, Heyser J, Schene AH, Tijssen JG, Hoogendijk WJ, Visser TJ & Fliers E. Polymorphism in the brain thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients. Clinical Endocrinology 2008 69 804-811.